Durable Responses and Survival in High-risk Myelodysplastic Syndrome and Acute Myeloid Leukemia Patients Receiving the Allogeneic Leukemia-derived Dendritic Cell Vaccine DCP-001.

ABSTRACT:

SUBMITTER: Janssen LLG 

PROVIDER: S-EPMC10624465 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature